Gastroenterology Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gastroenterology Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Liver Disease
Researchers from University of Verona discuss findings in liver disease
July 13th, 2009
According to a study from Verona, Italy, "Nonalcoholic fatty liver disease (NAFLD), comprising its whole spectrum of conditions ranging from simple steatosis to steatohepatitis (nonalcoholic steatohepatitis; NASH) and cirrhosis, is the most frequent liver disease in developed countries and is now regarded as the liver manifestation of the metabolic syndrome." "Several studies indicate that NAFLD, especially in its necro-inflammatory form (NASH), is associated with a systemic proinflammatory/prothrombotic state, independently of shared metabolic risk factors. This Suggests that NAFLD/NASH is not simply a marker of the proinflammatory/prothrombotic state in the metabolic...
Source: Gastroenterology Week (2009-07-13)
|
